Lyra Therapeutics Stock (NASDAQ: LYRA) stock price, news, charts, stock research, profile.
Open | $4.660 |
Close | $4.030 |
Volume / Avg. | 2.440M / 364.128K |
Day Range | 3.920 - 4.710 |
52 Wk Range | 2.360 - 6.790 |
Market Cap | $252.116M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 31 |
Short Interest | 0.46% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Lyra Therapeutics (NASDAQ: LYRA) through any online brokerage.
Other companies in Lyra Therapeutics’s space includes: Atea Pharmaceuticals (NASDAQ:AVIR), Zevra Therapeutics (NASDAQ:ZVRA), Xeris Biopharma Holdings (NASDAQ:XERS), Terns Pharma (NASDAQ:TERN) and Rani Therapeutics Hldgs (NASDAQ:RANI).
The latest price target for Lyra Therapeutics (NASDAQ: LYRA) was reported by HC Wainwright & Co. on Wednesday, May 1, 2024. The analyst firm set a price target for 12.00 expecting LYRA to rise to within 12 months (a possible 184.36% upside). 7 analyst firms have reported ratings in the last year.
The stock price for Lyra Therapeutics (NASDAQ: LYRA) is $4.22 last updated May 3, 2024 at 6:35 PM EDT.
There are no upcoming dividends for Lyra Therapeutics.
Lyra Therapeutics’s Q1 earnings are confirmed for Tuesday, April 30, 2024.
There is no upcoming split for Lyra Therapeutics.
Lyra Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.